Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LLY | Common Stock | Options Exercise | $0 | +6.3K | +80.3% | $0.00 | 14.1K | Jun 1, 2024 | Direct | |
transaction | LLY | Common Stock | Tax liability | -$2.5M | -3.05K | -21.53% | $820.34 | 11.1K | Jun 1, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LLY | Restricted Stock Unit | Options Exercise | $0 | -6.3K | -100% | $0.00* | 0 | Jun 1, 2024 | Common Stock | 6.3K | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |
F2 | The restricted stock units vested in three installments, 7,560 on June 1, 2022, 6,300 on June 1, 2023, and 6,300 on June 1, 2024. |